| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
ASCO 2022 update: (neo-)adjuvant treatment of colorectal cancer
|
Piringer, Gudrun
|
|
|
15 |
Suppl 6 |
p. 264-268
|
artikel
|
| 2 |
Cardiotoxicity—current recommendations of prevention and treatment
|
Bergler-Klein, Jutta
|
|
|
15 |
Suppl 6 |
p. 67-71
|
artikel
|
| 3 |
CAR T cells in multiple myeloma: Where we stand and where we might be going
|
Zojer, Niklas
|
|
|
15 |
Suppl 6 |
p. 185-189
|
artikel
|
| 4 |
Clinical characteristics and prognostic value of 1q21 gain detected by fluorescence in situ hybridization in patients with newly diagnosed multiple myeloma
|
Xiao, Xiao
|
|
|
15 |
Suppl 6 |
p. 90-93
|
artikel
|
| 5 |
Endometrial cancer: news from ASCO
|
Petru, Edgar
|
|
|
15 |
Suppl 6 |
p. 275-277
|
artikel
|
| 6 |
Essential news and practice changing trials in oesophageal, gastroesophageal junction and gastric cancer in 2021
|
Reimann, Patrick
|
|
|
15 |
Suppl 6 |
p. 238-242
|
artikel
|
| 7 |
High mortality in patients with active malignancy and severe COVID-19
|
Udovica, Simon
|
|
|
15 |
Suppl 6 |
p. 153-160
|
artikel
|
| 8 |
Molecular profiling in colorectal cancer
|
Piringer, Gudrun
|
|
|
15 |
Suppl 6 |
p. 206-210
|
artikel
|
| 9 |
New targeted therapies in kidney cancer
|
Mayrhofer, Karl
|
|
|
15 |
Suppl 6 |
p. 133-136
|
artikel
|
| 10 |
Pharmacokinetic drug interactions of oral anticancer drugs
|
Gampenrieder Satory, Julia
|
|
|
15 |
Suppl 6 |
p. 298-302
|
artikel
|
| 11 |
Renal cell carcinoma—presentation highlights from the ESMO Congress 2021
|
Hutterer, Georg C.
|
|
|
15 |
Suppl 6 |
p. 102-106
|
artikel
|
| 12 |
Tracking mutation and drug-driven alterations of oncokinase conformations
|
Feichtner, Andreas
|
|
|
15 |
Suppl 6 |
p. 137-142
|
artikel
|
Tijdschrift beschrijving